advertisement
Aihara M 18
Showing records 1 to 18 | Display all abstracts from Aihara M80985 Development of a Spherical Model with a 3D Microchannel: An Application to Glaucoma Surgery
Gallab M
Micromachines 2019; 10:
80947 Development and characterization of a new rat ocular hypertension model induced by intracameral injection of conjunctival fibroblasts
Nakagawa A
Scientific reports 2019; 9: 6593
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Aihara M
Journal of Glaucoma 2019; 28: 375-385
80947 Development and characterization of a new rat ocular hypertension model induced by intracameral injection of conjunctival fibroblasts
Sakai O
Scientific reports 2019; 9: 6593
80985 Development of a Spherical Model with a 3D Microchannel: An Application to Glaucoma Surgery
Omata S
Micromachines 2019; 10:
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Lu F
Journal of Glaucoma 2019; 28: 375-385
80947 Development and characterization of a new rat ocular hypertension model induced by intracameral injection of conjunctival fibroblasts
Tokushige H
Scientific reports 2019; 9: 6593
80985 Development of a Spherical Model with a 3D Microchannel: An Application to Glaucoma Surgery
Harada K
Micromachines 2019; 10:
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Kawata H; Iwata A
Journal of Glaucoma 2019; 28: 375-385
80985 Development of a Spherical Model with a 3D Microchannel: An Application to Glaucoma Surgery
Mitsuishi M
Micromachines 2019; 10:
80947 Development and characterization of a new rat ocular hypertension model induced by intracameral injection of conjunctival fibroblasts
Fujishiro T
Scientific reports 2019; 9: 6593
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Liu K
Journal of Glaucoma 2019; 28: 375-385
80947 Development and characterization of a new rat ocular hypertension model induced by intracameral injection of conjunctival fibroblasts
Aihara M
Scientific reports 2019; 9: 6593
80985 Development of a Spherical Model with a 3D Microchannel: An Application to Glaucoma Surgery
Sugimoto K
Micromachines 2019; 10:
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Odani-Kawabata N
Journal of Glaucoma 2019; 28: 375-385
80985 Development of a Spherical Model with a 3D Microchannel: An Application to Glaucoma Surgery
Ueta T; Totsuka K
Micromachines 2019; 10:
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Shams NK
Journal of Glaucoma 2019; 28: 375-385
80985 Development of a Spherical Model with a 3D Microchannel: An Application to Glaucoma Surgery
Araki F; Takao M; Aihara M; Arai F
Micromachines 2019; 10:
